Month, Year, Venue, City, State
Selected News & Events
Stealth BioTherapeutics Announces FDA Accelerated Approval of FORZINITY™ (elamipretide) injection, the First Therapy for Progressive and Life-limiting Ultra-rare Genetic Disease Barth Syndrome
STEALTH BIOTHERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF ELAMIPRETIDE NDA RESUBMISSION
STEALTH BIOTHERAPEUTICS RESUBMITS NEW DRUG APPLICATION FOR ELAMIPRETIDE FOR THE TREATMENT OF BARTH SYNDROME
Stealth BioTherapeutics Announces “Path Forward” Despite Disappointing Delay for Ultra-rare Barth Syndrome
Events Calendar
Event Name Placeholder
Contact Us
Stealth BioTherapeutics
123 Highland Ave, Suite 201
Needham, MA 02494
(617) 600-6888
info@stealthbt.com